Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inherited breast cancer

D M Radford1, B A Zehnbauer

  • 1Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

The Surgical Clinics of North America
|April 1, 1996
PubMed
Summary

Genetic mutations in BRCA1 and BRCA2 genes significantly increase hereditary breast cancer risk. Understanding these inherited predispositions is crucial for early detection and counseling high-risk individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?

The pharmacogenomics journal·2009
Same author

Extreme warfarin sensitivity in siblings associated with multiple cytochrome P450 polymorphisms.

American journal of hematology·2001
Same author

Genetic susceptibility to hemorrhagic complications during warfarin therapy.

Surgery·2001
Same author

Novel polymorphism in the FMR1 gene resulting in a "pseudodeletion" of FMR1 in a commonly used fragile X assay.

The Journal of molecular diagnostics : JMD·2001
Same author

Genetic markers in sepsis.

Journal of the American College of Surgeons·2001
Same author

Cytochrome P450 polymorphisms are associated with reduced warfarin dose.

Surgery·2000

Area of Science:

  • Oncology
  • Genetics
  • Medical Research

Background:

  • Hereditary factors contribute to 5-10% of all breast cancer cases.
  • Several inherited cancer syndromes are linked to increased breast cancer risk.
  • BRCA1 and BRCA2 gene mutations are key genetic drivers of hereditary breast cancer.

Purpose of the Study:

  • To review the genetics of breast cancer.
  • To address practical concerns for surgeons counseling high-risk patients.
  • To highlight the role of specific genes in hereditary breast cancer.

Main Methods:

  • Review of existing literature on breast cancer genetics.
  • Discussion of gene linkage analysis and mutation identification.
  • Exploration of predictive genetic testing methodologies.

Main Results:

  • BRCA1 mutations account for 45% of hereditary early-onset breast cancer.
  • BRCA2 mutations are responsible for approximately 40% of hereditary early-onset breast cancer.
  • Mutations in the ataxia-telangiectasia gene may contribute to 7% of breast cancer cases.

Conclusions:

  • Autosomal dominant inheritance of high-risk genes plays a significant role in breast cancer.
  • Genetic testing offers predictive insights for individuals with hereditary predispositions.
  • Surgeons must be equipped to counsel patients regarding genetic risks and testing options.

Related Experiment Videos